A novel silver (I) chelate: Cytotoxicity and apoptotic mechanism of action on human hematopoietic malignancies [11]

Leukemia

Volumn 22, Issue 2, 2008, Pages 448-450

  Batarseh, K I ^a  

^a Alpha Omega Biologicals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALIARGENTUMYCINE; ARSENIC TRIOXIDE; CHELATE; COORDINATION COMPOUND; CYTOTOXIC AGENT; GENTAMICIN; HEAVY METAL; IMATINIB; MERCAPTOPURINE; METAL COMPLEX; RETINOIC ACID; SILVER; SILVER CHELATE; SILVER DERIVATIVE; SILVER GLUTAMIC ACID CHELATE; SILVER TARTARIC ACID CHELATE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARGYRIA; AUTONOMIC NEUROPATHY; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; DNA METHYLATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG SYNTHESIS; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY TUBULE NECROSIS; LETTER; MULTIPLE MYELOMA; NAUSEA; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THROMBOCYTOPENIA;

EID: 39149133969     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404898     Document Type: Letter

References (8)

1. South J. Mild silver protein against internal and topical infections. www.smart-drugs.com/JamesSouth-silver.htm. (accessed May 2007).
2. Verstovsek S, Giles F, Quintas-Cardama A, Perez N, Ravandi-Kashani F, Beran M. Arsenic derivatives in hematological malignancies: A role beyond acute promyelocytic leukemia? Hematol Oncol 2006; 24: 181-188.
3. National Cancer Institute. In vivo screening data summary. http:// dtp.nci.nih.gov/dtpstandard(servlet/
4. Batarseh KI. Anomaly and correlation of killing in the therapeutic properties of silver (1) chelation with glutamic and tartaric acids. J Antimicrob Chemo 2004; 54: 546-548.
5. 2O3) on non-acute promylocytic leukemia myeloid cell lines: Induction of apoptosis and inhibition of proliferation. Br J Haemat 2002; 116: 555-563.
6. Daskalakis M, Nguyen T, Nguyen C, Guldberg P, Köhler G, Wijermans P et al. Demelthylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-aza-2′-deoxycytidine (decitabine) treatment. Blood 2002; 100: 2957-2964.
7. Munshi NC, Tricot G, Desikan R, Badros A, Zangari M, Toor A et al. Clinical activity of arsenic trioxide for the treatment of multiple myeloma. Leukemia 2002; 16: 1835-1837.
8. Jiang XH, Wong BC, Yuen ST, Jiang SH, Cho CH, Lai KC et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. JNCI 2001; 91 173-179.